Product Explainer

Enteric coated risedronate 35mg for the treatment of osteoporosis

Description

In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm

A/Prof Ralph Audehm

Lipids Management in GP Demystified

Dr Anita Munoz

Dr Anita Munoz

Maintaining Muscles of Independence – Sarcopenia Screening & Management

Dr Melissa Bochner

Dr Melissa Bochner

Work Up of a Breast Lump in GP – Practical Tips and Traps

Dr Adam Straub

Dr Adam Straub

Managing Opioid Dependence in GP – An Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Ego Seeman

expert

Prof Ego Seeman

Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis

Date published: 7 November 2023